ABSTRACT
Ferroptosis is a new type of programmed cell death, characterized by iron overload and lipid peroxidation. Cardiovascular disease (CVD) is an ischemic or hemorrhagic disease of the heart caused by various factors, mainly including myocardial infarction, heart failure, etc. Ferroptosis is involved in the process of myocardial cell damage and plays a driving role in the progression of various CVDs. Its main mechanisms include the destruction of iron homeostasis, the production of reactive oxygen species, the disorder of the antioxidant system, mitochondrial membrane damage, endoplasmic reticulum stress, tumor suppressor gene p53, transcription factor Nrf2 pathway, etc. Myocardial injury is one of the causes of death in many patients with heart disease. Monomers or compounds of traditional Chinese medicine have shown good effects in the treatment of myocardial cell injury caused by ferroptosis, including baicalin protecting cardiac microvascular endothelial cells of myocardial ischemia-reperfusion (I/R) rats through intracellular phosphatidylinositol kinase/phosphokinase B/endothelial nitric oxide synthase (PI3K/Akt/eNOS) pathway, Aralia elata saponin inhibiting myocardial cell ferroptosis through glucocorticoid receptor/p53/solute carrier family 7 members 11 (NR3C1/p53/SLC7A11) pathway, Xinyang tablets improving oxidative stress by regulating phosphorylated serine/threonine protein kinase/stress-activated protein kinase/p53 (MLK3/JNK/p53) signaling pathway. It is of great significance to explore the mechanism of ferroptosis and the protective effect of related traditional Chinese medicine after myocardial cell injury. This article reviews the mechanism of ferroptosis and its relationship with myocardial cells, as well as traditional Chinese medicine monomers and formulas for treating CVDs through the ferroptosis pathway. The article focuses on the pathways and effects of traditional Chinese medicine treatment, so as to provide a reference for the treatment of CVDs with traditional Chinese medicine.
ABSTRACT
Purpose: To investigate the quality of life (QoL) in a sample of color vision deficit (CVD) patients in India and how color vision deficiency affects them psychologically, economically, and in productivity related to their work and occupation. Methods: A descriptive and case–control study design using a questionnaire was conducted on N = 120 participants, of whom 60 were patients of CVD (52 male and eight female) who visited two eye facilities in Hyderabad between 2020 and 2021 and 60 were age?matched normal color vision participants who served as controls. We validated English–Telugu adapted version of CVD?QoL, developed by Barry et al. in 2017 (CB?QoL). The CVD?QoL consists of 27 Likert?scale items with factors (lifestyle, emotions, and work). Color vision was assessed using the Ishihara and Cambridge Mollen color vision tests. A six?point Likert scale was used, with lower scores indicating poor QoL (from 1 = severe issue to 6 = no problem). Results: The CVD?QoL questionnaire’s reliability and internal consistency were measured, including Cronbach’s ? (? =0.70–0.90). There was no significance between the group in age (t = ?1.2, P = 0.67) whereas the Ishihara colour vision test, scores showed a significant difference (t = 4.50, P < 0.001). The QoL scores showed a significant difference towards lifestyle, emotions and work (P = 0.001). The CVD group had a poorer QoL score than the normal color vision group odds ratio [OR] =0.31, 95% confidence interval [CI], (P = 0.002, CI = 0.14–0.65, Z = 3.0) . In this analysis, a low CI indicated that the OR was more precise. Conclusion: Color vision deficiency affects Indians’ QoL, according to this study. The mean scores of lifestyle, emotions, and work were lower than the UK sample. Since CVD is underreported and possibly affects developing countries more, advocacy for a new health care plan on CVD is essential. Increasing public understanding and awareness could also help diagnosing the CVD population
ABSTRACT
A study of Lipid profile in CKD patient is subject of interest due to impact on the individual and society as dyslipidaemia is one of the traditional risk factors for CVD which is responsible for most of the morbidity & mortality in CKD patient. And its study can lead to therapeutical result affecting both short term and long-term outcomes. To identify and analyse lipid AIMS & OBJECTIVE - alteration in CKD patients and study the correlation between renal function and lipid abnormalities in CKD Our study is hospital METHODS – based descriptive observational study for duration of 18 months. Study included 100 patients RESULTS – in which mean age was 51.88 and male to female ratio of 1.5:1. Prevalence of Lipid Profile abnormalities seen as HDL decreased in 100% patient and Cholesterol, LDL, Triglyceride increased in 40%, 24%, 64% patients respectively Dyslipidaemia is common among pa CONCLUSION - tients with CKD and predominant lipid profile abnormalities were reduced HDL and elevated Triglycerides. Hence regular monitoring of lipid profile should be done in patients of CKD
ABSTRACT
Introduction: Many studies showed that police officers complained about physical and mental health issues due to job stress. These work stresses lead to adop?ng unhealthy lifestyles and habits including the harmful use of alcohol and tobacco use which leads to high blood pressure, heart a?acks, and other NCDs. Methods: This cross-sec?onal study included all male police personnel of all cadres from nine police sta?ons of Karimnagar Mandal. WHO STEPS NCD survey ques?onnaires were used to collect basic soci-demographic informa?on, clinical history, stress, and anthropometry for measurements of CVD risk factors. Result: 253 police personnel with a mean age of 41.09 years enrolled from all cadres. 152 (60%) of police personnel had mul?ple cardiovascular risk factors. Hypercholesterolemia (37.2%) followed by a sedentary lifestyle (30.8%), and diabetes mellitus (14.6%) were important findings in this study. This study has also revealed an important link between preceding condi?ons for developing cardiovascular diseases such as pre-hypertension in 42.7% and impaired fas?ng glucose level in 25.7% of police personnel. Half of the study police personnel had a family history of NCDs and it was not sta?s?cally significant with service experience. There was a strong associa?on between years of experience and tobacco and alcohol use. Organiza?onal and opera?onal stress levels increased with the increase in years of experience in policing (p-value<0. 01). Conclusion: Smoking and alcohol consump?on were more prevalent among Police personnel which need to be controlled. Physical inac?vity was another important area. Their a?tude towards controlling the risk factors and prac?cing healthy behavior to safeguard from cardiovascular diseases has to be strengthened. It can be done by conduc?ng regular awareness camps, training sessions, and regular cardiac risk factor evalua?ons for all police personnel.
ABSTRACT
Single-cell multi-Omics(SCM-Omics)and spatial multi-Omics(SM-Omics)technologies provide state-of-the-art methods for exploring the composition and function of cell types in tissues/organs.Since its emergence in 2009,single-cell RNA sequencing(scRNA-seq)has yielded many groundbreaking new discoveries.The combination of this method with the emergence and development of SM-Omics tech-niques has been a pioneering strategy in neuroscience,developmental biology,and cancer research,especially for assessing tumor heterogeneity and T-cell infiltration.In recent years,the application of these methods in the study of metabolic diseases has also increased.The emerging SCM-Omics and SM-Omics approaches allow the molecular and spatial analysis of cells to explore regulatory states and determine cell fate,and thus provide promising tools for unraveling heterogeneous metabolic processes and making them amenable to intervention.Here,we review the evolution of SCM-Omics and SM-Omics technologies,and describe the progress in the application of SCM-Omics and SM-Omics in metabolism-related diseases,including obesity,diabetes,nonalcoholic fatty liver disease(NAFLD)and cardiovascular disease(CVD).We also conclude that the application of SCM-Omics and SM-Omics approaches can help resolve the molecular mechanisms underlying the pathogenesis of metabolic diseases in the body and facilitate therapeutic measures for metabolism-related diseases.This review concludes with an overview of the current status of this emerging field and the outlook for its future.
ABSTRACT
Objective@#To investigate the cardioprotective effect of Saffron (Crocus sativus L.) treatment as a potential supplement on patients with type 2 diabetes mellitus (T2DM).@*Methods@#Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were applied to analyze articles retrieved from PubMed, ScienceDirect, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), and China Biology Medicine (CBM) with a publication time span from January 15, 2015 to March 20, 2023. The articles were published in English only, including randomized controlled trials (RCTs) on adult patients who were diagnosed with T2DM, and received either Saffron or placebo treatment. Meta-analysis was performed using Review Manager 5.4 software. The present study was registered on the International Prospective Register of Systematic Reviews (PROSPERO) with a registration number as CRD42023443180.@*Results@#Seven RCTs with 455 patients were included in the study. The data revealed that Saffron treatment significantly reduced tumor necrosis factor (TNF)-α (P = 0.008) and fasting blood glucose (FBG) (P = 0.04) levels compared with what placebo did in T2DM patients. No significant differences were shown in the levels of interleukin (IL)-6, malondialdehyde (MDA), high serum C-reactive protein (hs-CRP), lipid profile, blood pressure, and body mass index (BMI) between Saffron and placebo ( P > 0.05) .@*Conclusion@#Saffron treatment has a cardioprotective effect in T2DM patients by reducing TNF-α and FBG levels. However, the potential anti-oxidant, anti-hypertensive, and anti-dyslipidaemia effects of the phytochemical need to be further investigated.
ABSTRACT
3 - Hydroxy - 3 - methylglutaryl - coenzyme, a reductase inhibitors (statins) are widely used drugs to reduce lipid levels by inhibiting cholesterol biosynthesis. Simvastatin, a lipophilic statin is one of the most frequently prescribed statin drugs throughout th e world due to profound reductions in LDL - C with excellent tolerability, with very little risk of important adverse effects, to a lower extent. It also reduce triglycerides and increase high - density lipoprotein cholesterol levels. Beside this, studies on simvastatin have shown to exhibit numerous pleiotropic effects, has beneficial effect on endothelial function, smooth muscle cell function, haemostasis, vascular wall function, LDL oxidation, kidney diseases, inflammation and anticarcinogenic effects on ma ny types of cancer including prostate, breast hepatic and colon carcinoma. In this review, we present a
ABSTRACT
Cardiovascular Diseases (CVDs) are taking the biggest toll on human health since the last few decades. Around the middle of the 20th century, morbidity and mortality due to CVDs began to increase exponentially due to drastic change in lifestyle and rapid urbanization. At that point of time a very little was known about its causes or risk factors. Identification of risk factors is crucial in planning the treatment and prevention strategies for any disease. Profound research works have been conducted worldwide to identify risk factors of CVDs. Conventional risk factors like obesity, smoking, hypertension, diabetes, dyslipidemia, physical inactivity etc are already given due importance in risk prediction, prevention and management of CVDs. The risk assessment tools available at present are mainly based on these conventional risk factors. Even after adjusting the conventional risk factors, CVD related morbidity and mortality are still growing. Moreover CVDs are now reported at an early age. Hence there is also a need to identify novel risk factors which can be helpful in predicting and identifying CVDs earlier. The future of CVD risk assessment is an integration of both traditional as well as emerging risk factors for better prediction, diagnosis and planning therapeutic and preventive interventions of CVDs.
ABSTRACT
As per current statistics, India accounts for more than 74 million individuals living with diabetes. Many of these individuals have associated cardiovascular disease (CVD) and chronic kidney disease (CKD) comorbidities. Optimal glycemic management is important because uncontrolled glycemia may accelerate the macrovascular and microvascular complications, further aggravating the comorbid conditions. Metformin is used as the first-line therapy in most persons. However, there are some who do not tolerate metformin, are unable to achieve required glycemic targets or require greater efforts for cardiovascular (CV) risk reduction. These patients require an alternative hypoglycemic agent to be used as either monotherapy or as combination treatment with metformin, respectively. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are one such novel class of drugs that can be used as either monotherapy or as part of two drug (dual) or three drug (triple) combinations with other oral hypoglycemic agents or insulin. Dapagliflozin is a promising option for managing type 2 diabetes with CV and renal benefits, weight and blood pressure reducing properties. A low risk of hypoglycemia and drug-drug interactions are the added advantages. In this article, the authors have reviewed the existing clinical evidences on dapagliflozin and highlighted its place in the diabetes management landscape
ABSTRACT
Introduction: Hypertension is a significant public health problem, with a worldwide prevalence of 40.8% and a control rate of 32.3. Hypertension is a noteworthy hazard factor for various genuine health conditions, including cardiovascular ailment, cerebrovascular malady, and constant kidney illness. Objectives of the study: The main objective of the study is to find the effect of blood pressure and hypertension in the risk assessment of heart diseases among young people.Methodology of the study: This study was conducted at Islam teaching hospital and Victoria hospital Bahawalpur, Pakistan. This study was conducted according to the rules and regulations of ethical committee of hospital. This research will help towards next findings of effect of blood pressure in hypertension and cardiovascular diseases.Results: The data shows that there is a significant relationship between hypertension and CVD. There is also some positive relationship between socio-economic status and hypertension with respect to CVD. Conclusion: In conclusion, the current hypertension paradigm does not account for the continuous risk associated with elevated BP or the multifactorial nature of CVD, the primary consequence of elevated BP.
ABSTRACT
@#Introduction Lead (Pb) is one of the pollutants that can cause adverse effects on human health. Exposure to Pb has received much attention in the past decades due to its nearly persistent properties in the environment. Blood Pb measurement is the most convenient as well as most feasible to indicate toxicity exceeded the standard limit of 10 μg/dL. This study aimed to assess the association between blood Pb and myocardial infarction. Methods This was a case-control study conducted at a tertiary hospital in Kuala Lumpur, Malaysia. This study enrolled about 109 respondents; 71 cases of myocardial infarction and 38 non-cases of myocardial infarction. Study instruments include questionnaires on demographic factors (age, gender, and ethnicity), socioeconomic factors (education, household income, occupation), and venous blood lead level. The blood Pb was measured using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Results The median (IQR) of blood Pb among the case group was higher compared to the control groups, 3.72 (0.04 – 96.09) μg/dL and 2.81 (0.73 – 6.23) μg/dL respectively. No difference between high (> 10 μg/dL) and normal (<10 μg/dL) blood Pb with CVD. However, there was a significant association between high normal blood Pb concentration (≥ 5.00 µg/dL) and myocardial infarction (χ2 = 4.397; p = 0.036). Conclusions There is a relationship between lower blood Pb level and the occurrence of myocardial infarction. No difference was found between the blood Pb limit of 10 μg/dL and CVD. The findings of this study are very important and provide new information regarding the lower cut off point for blood Pb and outcome of CVD especially myocardial infarction..
ABSTRACT
@#Introduction: Cardiovascular disease (CVD) remains the leading cause of death in Malaysia. Identification of asymptomatic at-risk individuals is often achieved by means of a risk prediction algorithm. Traditional CVD risk factors and their associated algorithms are, however, limited by residual CVD risk. High sensitivity C-reactive protein (hsCRP) has emerged as a novel CVD risk factor. This study aimed to evaluate hsCRP as an adjunct CVD risk marker among the adult Malaysian population by determining its correlation with the Framingham Risk Score (FRS). Comparison analyses were done according to sociodemographic, clinical and laboratory factors and between subjects with and without Metabolic Syndrome (MetS). Method: This cross-sectional study involved eighty-three (n=83) adults attending a health screening program at Universiti Putra Malaysia (UPM). Demographic data, anthropometric measurements and blood samples for fasting blood glucose (FBG), fasting lipid profile (FSL), glycated haemoglobin (HbA1c) and hsCRP were taken. Respondents were grouped according toFRSand the Joint Interim Statementinto 10-year CVD risk categories (low, intermediate and high) and MetS, respectively. Results: hsCRP was significantly increased in patients with high body mass index (BMI) (p=0.001), at-risk waist circumference (WC) (p=0.001) and MetS (p=0.009). Spearman’s correlation coefficient showed a significant positive correlation between hsCRP level and total FRS score (r=0.26, p<0.05) and HDL-C score (r=0.22, p<0.05). Conclusion: The significant difference of hsCRP levels across obesity levels and MetS with its modest correlation with FRS scores supported the adjunctive role of hsCRP in CVD risk prediction, most likely capturing the inflammatory pathological aspect and thus partly accounting for the residual CVD risk.
ABSTRACT
Objective@#The study aims to predict 10-year cardiovascular disease (CVD) risk and explore its association with sleep duration among Chinese urban adults.@*Methods@#We analyzed part of the baseline data of a cohort that recruited adults for health screening by cluster sampling. The simplified Pittsburgh Sleep Quality Index (PSQI) and Framingham 10-year risk score (FRS) were used to measure sleep duration and CVD risk. Demographic characteristics, personal history of chronic diseases, lifestyle factors were collected using a questionnaire. Height, weight, total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) were also measured. Multiple logistic regression models were performed to explore the association of sleep duration with the predicted CVD risk.@*Results@#We included 31, 135 participants (median age 44 years, 53.02% males) free of CVD, cerebral stroke, and not taking lipid-lowering agents. Overall, 14.05%, and 25.55% of participants were at medium and high predicted CVD risk, respectively. Short sleep was independently associated with increased odds of medium to high risk of predicted 10-year CVD among males ( @*Conclusion@#A substantial number of adults free of CVD were at high 10-year CVD risk. Short sleep was associated with increased odds of predicted CVD risk.
Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Cardiovascular Diseases/etiology , China/epidemiology , Risk Factors , Sleep QualityABSTRACT
Objective To analyze the epidemic trends and risk factors of cardiovascular disease (CVD) burden in China from 1990 to 2019, based on the Global Burden of Disease (GBD) study 2019, by comparing with the world, the USA, Japan and India. Methods Data were obtained from the Global Health Data Exchange (GHDx) database, and the prevalence, incidence, mortality, disability adjusted life years (DALY) rate and main risk factors of CVD in China in 2019 were analyzed by gender and age. Age-standardized rates were used to compare the trends of CVD burden in the world and other four countries. Results In 2019, the number of CVD patients, incidences and deaths in China was 120.33 million, 12.34 million, and 4.58 million, respectively. The prevalence, morbidity, mortality and DALY rate increased from 4 235.43/100 000, 447.81/100 000, 204.75/100 000 and 5 091.03/100 000 in 1990 to 8 460.08/100 000, 867.65/100 000, 322.30/100 000, and 6 463.47/100 000 in 2019, respectively, all of which were increasing with age. The burden of CVD in males was higher than that in females. After eliminating the influence of population aging, the age-standardized mortality rate of CVD in China decreased from 381.21/100 000 in 1990 to 276.93/100 000 in 2019, and the age-standardized DALY rate decreased from 7 412.81/100 000 to 4 938.38/100 000. However, they were still slightly higher than those in the world and significantly higher than those in the USA and Japan. In addition, the leading four risk factors of CVD in China in 2019 were hypertension, dietary risks, air pollution and tobacco. A higher burden of CVD caused by all these factors in China were above the global average level. Conclusion Due to hypertension, dietary factors, air pollution, tobacco and other reasons, coupled with the rapid aging of the population, the burden of CVD in China is still very serious, and relevant departments need to pay more attention to it.
ABSTRACT
HMG-CoA reductase (HMGCR) protein is usually upregulated after statin (HMGCR inhibitor) treatment, which inevitably diminishes its therapeutic efficacy, provoking the need for higher doses associated with adverse effects. The proteolysis targeting chimera (PROTAC) technology has recently emerged as a powerful approach for inducing protein degradation. Nonetheless, due to their bifunctional nature, developing orally bioavailable PROTACs remains a great challenge. Herein, we identified a powerful HMGCR-targeted PROTAC (
ABSTRACT
Background: Cardio vascular disease (CVD) is the number 1 cause of death globally and an estimated 17.7 million people died from CVD in 2015, representing 31% of all global deaths. In India CVD accounts for 25% of all deaths. The objectives of the study was to estimate the prevalence of CVD among the study population and to determine the association between CVD and various risk factors.Methods: This is a cross sectional study carried out in the rural field practice area attached to SBMCH. The study group were 400 adults (20-60 years). The data was collected using a structured questionnaire containing socio-demographic particulars, details regarding CVD risk factors and physical measurements. Data was entered in MS Excel and analysed using SPSS 15 software.Results: Prevalence of CVD is 24.3% and of which hypertension (18%), coronary artery disease (6%), stroke (2.2%) and valvular heart disease (1%). The prevalence of risk factors are age >40 (63%), tobacco use (17.8%), alcohol use (22.3%), physical inactivity (52%), unhealthy diet (61.4%), obesity (19.7%), diabetes (13.6%) and positive family history (21.4%). There is a strong statistically significant association between CVD and age (p=0.008, OR-1.968), tobacco use (p<0.0001, OR-10.029), obesity (p<0.0001, OR-13.462) and positive family history (p<0.0001, OR-13.964).Conclusions: In this study prevalence of CVD is high. It is necessary to minimize the burden of growing CVD by controlling the rates of the risky behaviours by lifestyle modification and by increasing awareness regarding CVD.
ABSTRACT
Objectives@#This study aims to (1) determine the cardiovascular risk of persons with hypertension and diabetes attending hypertension/diabetic clinics or hypertension/health club meetings in the AMIGA (Alfonso, Mendez, Indang, General Emilio Aguinaldo and Amadeo) municipalities of Cavite; (2) suggest measures to improve the cardiovascular disease (CVD) program in these municipalities using the results of the study. @*Methods@#A cross-sectional study was performed on patients diagnosed with hypertension and/or diabetes who are attending clinics or club meetings in the barangays of the five AMIGA municipalities of Cavite. Participants were interviewed using an abbreviated version of the World Health Organization (WHO) STEPS questionnaire on risk factors. The participants’ anthropometric measurements were obtained and their total blood cholesterol levels determined. CVD risk was then estimated using the WHO / International Society of Hypertension (ISH) risk prediction chart for the Western Pacific Region B. @*Results@#1,032 participants from 27 barangays qualified for the study. Participants were predominantly female (74%); over-all mean age was 58.43 years. The majority of the participants (79.17%) were found to be in the low-risk group; 11.34% were in the moderate risk group; 4.46% were in the high-risk group; while 5.05% were in the very high-risk group. Majority of the participants were also found to be obese. Mean total cholesterol was 207.02 mg/dl. @*Conclusion@#Majority of participants were stratified in the low-risk category (<10% chance to have cardiovascularevents in the next 10 years), while 9.5% were in the high-risk category (≥20% risk). Obesity is a major risk factor that could be addressed in this population.
Subject(s)
Cardiovascular Diseases , Risk Assessment , World Health OrganizationABSTRACT
Coronary dominance is decided on the basis of the origin of posterior descending artery. There are 3 types of dominance, right, left and co-dominance. BMI (Body Mass Index) is a measure of body fat based on height and weight. On the basis of BMI, population is categorized into underweight, normal, overweight and obese. There has been studies to find a relation between BMI and cardiovascular disease but there has been a very few studies to find if there is a correlation between coronary dominance and BMI. Our study is aimed to find if there is a relationship between the two. Coronary dominance was assessed through angiograms and BMI by height and weight and statistical tools were applied to see the relationship.
ABSTRACT
Inflammation plays a vital role in accentuating the formation of atherosclerotic plaque in diabetes mellitus. So, the measurements of inflammatory markers provide a method of assessing cardiovascular risk. Among the inflammatory markers, highly sensitive C-reactive protein (hs-CRP) is used to detect the low-level inflammation when it is within the normal range. Also, hs-CRP measurement may be useful for assessment of the risk of complication in diabetes patients. So, the present study is conducted to measure plasma hs-CRP level in T2DM and to determine adequate glycaemic control reduces hs-CRP level. The objectives of this study were to correlate HbA1c and hs-CRP in T2DM and predict cardiovascular risk with glycaemic status.Methods: Authors took 50 diabetic patients. The investigation includes FBS, PPBS, hs-CRP and HbA1c. hs-CRP is measured by immunoturbidimetry method. The reports were collected and compared with normal reference range.Results: The correlation between hs-CRP levels and HbA1c level after six months show a significant relationship where mean HbA1c values on day 1 and after 6 months were 8.088±1.219 and 7.518±0.693 respectively. The hs-CRP values were 2.508±1.050 on day 1 and 2.15±0.927 after 6 months proving that better glycaemic controls decrease hs-CRP thereby decreasing cardiovascular risk.Conclusions: hs-CRP values are directly related to HbA1c and better glycaemic control reduces risk of CVD.
ABSTRACT
Background: Metabolic syndrome (MS) is a pre-condition for cardiovascular diseases and type 2 diabetes mellitus (T2DM) which are major contributors to morbidity and mortality worldwide.Methods: The cross-sectional, observational study was conducted to estimate the proportion of MS and to explore crucial risk factors for MS among adult patients attending medicine OPD in a tertiary care hospital in West Bengal. The estimated final sample size was 315. Baseline socio demographic information and information on risk factors for MS, such as dietary habit, physical activity status, substance use, intake of related drugs, and presence of co-morbidities were collected by interviewing the patients with the help of a predesigned, pretested, structured schedule. Anthropometric measurements such as weight, height, waist circumference recordings were taken, and blood pressure was measured.Results: About 64% of the final study population (210/330) suffered from MS. On bivariate analysis, significant association between female gender (df=1, Pearson chi-square=5.06, p=0.024), weekly frequency of consumption of junk foods (df=3, Pearson chi-square=10.40, p=0.015) and obesity according to BMI (independent samples Mann-Whitney U test, p=0.010) at 5% level of significance were observed. Performing binary logistic regression analysis, obesity according to BMI (AOR=1.388, 95% CI=1.064-1.810) was found to be significant.Conclusions: Majority of the population suffered from MS who were mostly female, obese and consumers of junk foods. Appropriate interventional measures in terms of life style modification both at community and at tertiary care level are the need of the hour.